Literature DB >> 30712468

Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.

Kevin Duff1, Dana McDermott2, Dan Luong2, Christopher Randolph3, Adam L Boxer2.   

Abstract

Progressive supranuclear palsy (PSP) is associated with a variety of cognitive deficits, as well as motor and psychiatric disturbances. As clinical trials for PSP evolve, briefer screening instruments will be needed to determine cognitive effects of interventions. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) may fill this gap. Three hundred four participants diagnosed with Richardson's syndrome of PSP were evaluated with the RBANS, as well as other scales typically used in PSP. RBANS performances for these participants fell significantly below expectations for the Total Scale score and all five Indexes. Cognitive scores on the RBANS were also significantly related to other markers of PSP (e.g., motor and functional abilities, depression, global cognition). Compared to other clinical conditions from the literature, patients with PSP show impairment on tests of visuospatial perception and construction and attention. Although additional research is needed, the current study supports the clinical applicability of the RBANS in patients with PSP, as well as its potential for future clinical trials.

Entities:  

Keywords:  Cognition; Repeatable Battery for the Assessment of Neuropsychological Status; dementia; neurological disease; progressive supranuclear palsy

Mesh:

Year:  2019        PMID: 30712468      PMCID: PMC6499681          DOI: 10.1080/13803395.2019.1572073

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  30 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.

Authors:  M Cotelli; B Borroni; R Manenti; A Alberici; M Calabria; C Agosti; A Arévalo; V Ginex; P Ortelli; G Binetti; O Zanetti; A Padovani; S F Cappa
Journal:  Neuropsychology       Date:  2006-09       Impact factor: 3.295

3.  Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).

Authors:  T H Bak; L M Crawford; V C Hearn; P S Mathuranath; J R Hodges
Journal:  Neurocase       Date:  2005-08       Impact factor: 0.881

4.  A clinical rating scale for progressive supranuclear palsy.

Authors:  Lawrence I Golbe; Pamela A Ohman-Strickland
Journal:  Brain       Date:  2007-04-02       Impact factor: 13.501

5.  Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.

Authors:  P Soliveri; D Monza; D Paridi; F Carella; S Genitrini; D Testa; F Girotti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

6.  [The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status)].

Authors:  Tetsumori Yamashima; Manami Yoshida; Kazuhiko Kumahashi; Mie Matsui; Yoshifumi Koshino; Masato Higashima; Tatsuya Nagasawa; Akira Ueki; Mieko Ohtsuka; Shozo Aoki; Shinya Imuro; Norio Mori; Norichika Takei; Ryouichi Hoshino; Yoshio Minabe; Yoshio Nanba; Mayumi Nanba; Jun-ichi Kira; Yasumasa Ohyagi; Joh Haraoka; Jiro Akimoto; Nobuyoshi Miura; Shingo Kimura; Masaaki Matsushita
Journal:  No To Shinkei       Date:  2002-06

7.  Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS.

Authors:  William W Beatty; Katherine A Ryder; Samuel T Gontkovsky; James G Scott; Kelli L McSwan; Kersi J Bharucha
Journal:  Arch Clin Neuropsychol       Date:  2003-07       Impact factor: 2.813

8.  Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Kevin Duff; Leigh J Beglinger; Danielle Theriault; Jessica Allison; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2009-05-29       Impact factor: 2.475

9.  Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers.

Authors:  Kevin Duff; Joy D Humphreys Clark; Sid E O'Bryant; James W Mold; Randolph B Schiffer; Patricia B Sutker
Journal:  Arch Clin Neuropsychol       Date:  2008-07-17       Impact factor: 2.813

10.  Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.

Authors:  D C Paviour; D Winterburn; S Simmonds; G Burgess; L Wilkinson; N C Fox; A J Lees; M Jahanshahi
Journal:  Neurocase       Date:  2005-08       Impact factor: 0.881

View more
  5 in total

1.  Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.

Authors:  Kevin Duff; Christopher Randolph; Adam L Boxer
Journal:  Clin Neuropsychol       Date:  2019-09-27       Impact factor: 3.535

2.  Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.

Authors:  Andrea Horta-Barba; Javier Pagonabarraga; Saül Martínez-Horta; Laura Busteed; Berta Pascual-Sedano; Ignacio Illán-Gala; Juan Marin-Lahoz; Ignacio Aracil-Bolaños; Jesús Pérez-Pérez; Frederic Sampedro; Helena Bejr-Kasem; Jaime Kulisevsky
Journal:  J Neurol       Date:  2021-03-11       Impact factor: 4.849

3.  The Evaluation of Cognitive Impairment in Alcohol-Dependent Patients Through RBANS Combined With ERPs.

Authors:  Hui Cao; Chao Hou; Saiping Huang; Xiafeng Zhou; Jun Yang; Jia Bin Xu; Xiaoyun Cao; Zhenguang Li; Wei Zhang; Mei Zhang; Xuejun Liu; Xuhui Zhou
Journal:  Front Psychiatry       Date:  2021-01-21       Impact factor: 4.157

Review 4.  Four-Repeat Tauopathies: Current Management and Future Treatments.

Authors:  Lawren VandeVrede; Peter A Ljubenkov; Julio C Rojas; Ariane E Welch; Adam L Boxer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

5.  Open-Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy.

Authors:  Lawren VandeVrede; Marian L Dale; Scott Fields; Megan Frank; Emma Hare; Hilary W Heuer; Kellie Keith; Mary Koestler; Peter A Ljubenkov; Dana McDermott; Noelle Ohanesian; Jennifer Richards; Julio C Rojas; Elisabeth H Thijssen; Christine Walsh; Ping Wang; Amy Wolf; Joseph F Quinn; Richard Tsai; Adam L Boxer
Journal:  Mov Disord Clin Pract       Date:  2020-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.